It is exactly eight years since Paul Smith launched his womenswear collection on the London catwalk. He was prompted, he said at the time, by women who borrowed their boyfriends’ jackets and shirts and even bought “Smithy clothing” as he put it, in small sizes for themselves. and we have had confirmed by the judge that we followed the guidelines laid down by the Secretary of State.”. Residents were evacuated from their homes today after a suspicious substance was found during a police operation. West Midlands Police said a 100-metre cordon had been placed around the site of the discovery in Bartley Green, Birmingham.
A force spokesman said: “Police have this morning evacuated properties in the Long Nuke Road area. “This follows the execution of a warrant at a property in Long Nuke Road, where a suspicious substance was recovered.

She told the court at an earlier hearing that denying her the drug was tantamount to a death sentence.After yesterday’s ruling she was too upset to talk, but her solicitor, Yogi Amin, said: “Ann Marie is devastated at the outcome of this judicial review, but is determined to take her fight for this drug to the Court of Appeal.”Jan Stubbings, chief executive of Swindon PCT, said: “We considered her case within our own procedures, within the equitable framework we use … Mrs Rogers, a former restaurant manager, initially borrowed £5,000 to fund private Herceptin prescriptions, but cannot afford to pay for any more. Accordingly, despite my sympathy for Mrs Rogers’s plight, I must dismiss the claim for judicial review.”The judge ordered that Mrs Rogers should continue to receive Herceptin on the NHS until the end of next month, when the appeal will be heard. Mrs Rogers has not shown that Swindon PCT’s refusal to fund her treatment with Herceptin is contrary to a direction or guidance from the Secretary of State for Health. But until it receives the new licence and the National Institute for Clinical Excellence (Nice) decides what criteria should be applied when providing it on the NHS, it is up to the discretion of PCTs on who is given access to Herceptin.Mrs Rogers was told by Swindon PCT that it was only prescribing the drug in “exceptional” cases and that she was not eligible, despite her doctor’s prediction that there was a 57 per cent chance of her cancer returning within 10 years.In the High Court hearing last week, lawyers for Mrs Rogers argued that the PCT was acting unlawfully and in breach of informal guidance from the Health Secretary, Patricia Hewitt, that Herceptin should be made available unless there were safety concerns about its side effects.But Mr Justice Bean said yesterday: “The court’s task is not to say which policy is better, but to decide whether Swindon’s policy is arbitrary or irrational and thus unlawful. Campaigners claim trusts are denying patients Herceptin on the grounds of cost, although it can halve the risk of the disease returning.Mrs Rogers, 54, said she was “devastated and angry” and intended to appeal.

She was diagnosed early with an aggressive form of breast cancer in 2004 and, after a mastectomy, chemotherapy and radiotherapy, was judged to be an appropriate candidate for Herceptin.The drug has been licensed for advanced cancer and is expected to receive approval for treating early stages of the disease this year.One in five of the 40,000 women who are diagnosed with breast cancer each year could be helped by the drug. The vast majority will have already received letters with a shortfall projection, known as “red” letters. The three-year deadline starts with that letter.Not all complaints about endowments will be upheld, of course. The FSA stresses that receiving a red letter does not automatically mean you are entitled to compensation.

That will only be awarded if the insurer, or the Ombudsman, accepts the home owner was mis-sold the policy. Poor investment performance alone is not enough.And even if home owners do intend to complain, they still need to act to address the endowment shortfall. This could be by increasing their endowment premiums, paying into another investment vehicle, such as an Isa, or switching all or part of the loan to a repayment mortgage. Selling the endowment policy is by no means the only, or best option.”Making a snap judgement to get rid of the endowment is not always the best idea,” cautions David Hollingworth, director at mortgage brokers London & Country.